Clinical Trial Update: Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluated whether combining Tenofovir disoproxil fumarate with peginterferon alfa-2a improves efficacy and safety versus TDF or peginterferon…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Pegasys (pegylated interferon alfa-2a)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis B | Phase 4 | Status: COMPLETED | Results posted: 2015-09-09